| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0025700 | Exon-Exon | chr3:172064117-172065151 | chr3:172346327-172347361 | 120 nt | 0.4750 |
| hsa_FNDC3B_0025500 | Exon-Exon | chr3:172064117-172070873 | chr3:172346327-172353083 | 545 nt | 0.5009 |
| hsa_FNDC3B_0025800 | Exon-Exon | chr3:172064117-172080635 | chr3:172346327-172362845 | 114 nt | 0.4737 |
| hsa_FNDC3B_0025900 | Exon-Exon | chr3:172064117-172098883 | chr3:172346327-172381093 | 114 nt | 0.4737 |
| hsa_FNDC3B_0025600 | Exon-Exon | chr3:172064117-172115282 | chr3:172346327-172397492 | 1382 nt | 0.4783 |
| hsa_chr3_0368700 | Intergenic-Intergenic | chr3:172064184-172070722 | chr3:172346394-172352932 | 47 nt | 0.4468 |
| hsa_chr3_0368800 | Intergenic-Intergenic | chr3:172064184-172070867 | chr3:172346394-172353077 | 472 nt | 0.5000 |
| hsa_FNDC3B_0026000 | Exon-Exon | chr3:172065002-172070873 | chr3:172347212-172353083 | 150 nt | 0.4467 |
| hsa_FNDC3B_0026100 | Exon-Exon | chr3:172065002-172098883 | chr3:172347212-172381093 | 150 nt | 0.4467 |
| hsa_FNDC3B_0026200 | Intron-Intron | chr3:172066985-172067540 | chr3:172349195-172349750 | 556 nt | 0.3597 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].